SMAD2 antibody (pSer250) (Cy3)
Quick Overview for SMAD2 antibody (pSer250) (Cy3) (ABIN6983957)
Target
See all SMAD2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer250
-
Cross-Reactivity
- Human, Mouse
-
Predicted Reactivity
- Rat,Dog,Cow,Pig
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthesised phosphopeptide derived from human Smad2 around the phosphorylation site of Ser250
-
Isotype
- IgG
-
-
-
-
Application Notes
- FCM 1:20-100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- SMAD2 (SMAD, Mothers Against DPP Homolog 2 (SMAD2))
-
Alternative Name
- Smad2
-
Background
-
Synonyms: Smad2 (phospho S250), p-Smad2 (phospho S250), hMAD 2, hMAD 3, hSMAD2, hSMAD3, Mad related protein 2, MADH2, MADH3, MADR2, Mothers against DPP homolog 2, Mothers against DPP homolog 3, Sma and Mad related protein 2, SMA and MAD related protein 3, SMAD 2, SMAD 3, SMAD family member 2, SMAD family member 3.
Background: Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma.
-
Gene ID
- 4087
-
UniProt
- Q15796
-
Pathways
- Cell Division Cycle, Hormone Transport, Chromatin Binding, Protein targeting to Nucleus
Target
-